Clinical Trial Update: The Impact of Oral Vitamin C in Prevention for Post Operative Atrial Fibrillation (POAF) in Coronary Artery Bypass Surgery (CABG) Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether oral vitamin C prevents post-operative atrial fibrillation in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Grafting Complication
• Postoperative Atrial Fibrillation

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Helwan University | Conditions: Post Operative Atrial Fibrillation | Phase 4 | Status: UNKNOWN